4587 PeptiDream Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4587

TSE Prime

PeptiDream Inc.

2,416.5

JPY

-53.5

(-2.17%)

Jan 9, 3:30 pm JST

15.28

USD

Jan 9, 1:30 am EST

Result

PTS

outside of trading hours

2,423

Jan 9, 10:41 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2020	11,677	6,991	6,976	4,448	35.4	0	Feb 10, 2021	J-GAAP
Dec, 2021	9,365	4,418	4,774	3,606	28.0	0	Feb 9, 2022	J-GAAP
Dec, 2022	26,852	8,980	6,653	7,554	58.2	0	Feb 14, 2023	IFRS
Dec, 2023	28,712	6,773	4,353	3,035	23.4	0	Feb 14, 2024	IFRS
Dec, 2024 Guidance	45,000	20,100	19,900	14,000	108.0	0	May 14, 2024	IFRS
YoY	+56.7%	+196.8%	+357.2%	+361.3%	+361.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jun, 2019	Aug 9, 2018	7,200	3,300	3,600	2,600	0	J-GAAP
Results	Aug 8, 2019	7,216	3,579	3,806	2,770	0	J-GAAP
Dec, 2019 Changed	Aug 8, 2019	1,000	-900	-800	-600	0	J-GAAP
Results Changed	Feb 13, 2020	1,037	-887	-706	-488	0	J-GAAP
Dec, 2020	Feb 13, 2020	Available in future release
	Jan 4, 2021
Results	Feb 10, 2021
Dec, 2021	Feb 10, 2021
	Dec 22, 2021
Results	Feb 9, 2022
Dec, 2022	Feb 9, 2022
	May 12, 2022
	Nov 10, 2022
	Jan 18, 2023
Results	Feb 14, 2023
Dec, 2023	Feb 14, 2023
Results	Feb 14, 2024
Dec, 2024	Feb 14, 2024	35,000	10,500	10,200	7,300	0	IFRS
	May 14, 2024	45,000	20,100	19,900	14,000	0	IFRS

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jun, 2008	60	－	Available in future release
Jun, 2009	86	+43.3
Jun, 2010	91	+5.8
Jun, 2011	601	+560.4
Jun, 2012	269	-55.2
Jun, 2013	678	+152.0
Jun, 2014	818	+20.6
Jun, 2015	2,474	+202.4
Jun, 2016	4,327	+74.9
Jun, 2017	4,895	+13.1
Jun, 2018	6,426	+31.3
Jun, 2019	7,216	+12.3
Dec, 2019 Changed	1,037	－
Dec, 2020	11,677	+1,026.0
Dec, 2021	9,365	-19.8
Dec, 2022	26,852	+186.7
Dec, 2023	28,712	+6.9
Dec, 2024 Guidance	45,000	+56.7	20,100	+196.8	19,900	+357.2	108.0	+361.5

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2022	26,852	8,980	33.4	26.50	16.70	0.59	58.2
Dec, 2023	28,712	6,773	23.6	8.39	4.55	0.43	23.4
Dec, 2024 Guidance	45,000	20,100	44.7	23.94	14.98	0.48	108.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	28,712	8,980	6,976	7,554	58.2
Fiscal Year	Dec, 2023	Dec, 2022	Dec, 2020	Dec, 2022	Dec, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2021	6,486	3,600	3,692	2,836	22.0	0	Feb 9, 2022	J-GAAP
Jul - Dec, 2022	21,828	10,645	8,243	8,686	66.9	0	Feb 14, 2023	IFRS
Jul - Dec, 2023	19,286	7,759	5,463	3,764	29.0	0	Feb 14, 2024	IFRS
Jul - Dec, 2024 Guidance	8,867	-4,549	-4,842	-3,925	-30.3	0	Aug 8, 2024	IFRS
YoY	-54.0%	－	－	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2021	4,418	4,371	6,654	-2,283	66	11,746	44.13	J-GAAP
Dec, 2022	8,980	-27,459	-82	-27,377	20,789	5,247	8.22	IFRS
Dec, 2023	6,773	13,722	12,420	1,302	264	19,507	28.08	IFRS

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	11,208	-426	-368	-186	-1.4	ー	Nov 10, 2022	IFRS
Jan - Sep, 2023	22,543	6,752	4,661	3,541	27.3	107.1	Nov 9, 2023	IFRS
Jan - Sep, 2024	41,604	24,522	24,300	17,620	136.0	122.1	Nov 13, 2024	IFRS
YoY	+84.6%	+263.2%	+421.3%	+397.6%	+398.0%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	15,644	9,406	7,021	7,740	59.6	60.1	Feb 14, 2023	IFRS
Jan - Mar, 2023	4,963	-266	-399	-248	-1.9	-5.4	May 11, 2023	IFRS
Apr - Jun, 2023	4,463	-720	-711	-481	-3.7	-16.1	Aug 9, 2023	IFRS
Jul - Sep, 2023	13,117	7,738	5,771	4,270	32.9	59.0	Nov 9, 2023	IFRS
Oct - Dec, 2023	6,169	21	-308	-506	-3.9	0.3	Feb 14, 2024	IFRS
Jan - Mar, 2024	4,225	-1,098	-1,104	-842	-6.5	-26.0	May 14, 2024	IFRS
Apr - Jun, 2024	31,908	25,747	25,846	18,767	144.8	80.7	Aug 8, 2024	IFRS
Jul - Sep, 2024	5,471	-127	-442	-305	-2.4	-2.3	Nov 13, 2024	IFRS
YoY	-58.3%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	643	-56.1	Available in future release
Jan - Mar, 2020	393	－
Apr - Jun, 2020	2,714	－
Jul - Sep, 2020	725	－
Oct - Dec, 2020	7,845	－
Jan - Mar, 2021	1,459	+271.2
Apr - Jun, 2021	1,420	-47.7
Jul - Sep, 2021	4,884	+573.7
Oct - Dec, 2021	1,602	-79.6
Jan - Mar, 2022	419	-71.3
Apr - Jun, 2022	4,605	+224.3
Jul - Sep, 2022	6,184	+26.6
Oct - Dec, 2022	15,644	+876.5
Jan - Mar, 2023	4,963	+1,084.5
Apr - Jun, 2023	4,463	-3.1
Jul - Sep, 2023	13,117	+112.1
Oct - Dec, 2023	6,169	-60.6
Jan - Mar, 2024	4,225	-14.9
Apr - Jun, 2024	31,908	+614.9
Jul - Sep, 2024	5,471	-58.3	-127	－	-442	－	-2.4	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	31,908	25,747	25,846	18,767	144.8
Fiscal Year	Jun, 2024	Jun, 2024	Jun, 2024	Jun, 2024	Jun, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2021	192.39	93.8	26,619	24,977	17,543	ー	Feb 9, 2022	J-GAAP
Dec, 2022	246.63	50.2	63,865	32,041	23,848	0.66	Feb 14, 2023	IFRS
Dec, 2023	311.16	58.1	69,464	40,349	27,804	0.55	Feb 14, 2024	IFRS
Jan - Sep, 2024	ー	62.6	93,430	58,469	51,964	0.35	Nov 13, 2024	IFRS

PeptiDream Inc.(4587) Financial Results